©The Author(s) 2025.
World J Stem Cells. Aug 26, 2025; 17(8): 108898
Published online Aug 26, 2025. doi: 10.4252/wjsc.v17.i8.108898
Published online Aug 26, 2025. doi: 10.4252/wjsc.v17.i8.108898
Table 1 Characteristics and methodology for the formation of glioblastoma tumor model (spheroids or cells)
| Ref. | Tumor model (method) | Cell number | Cell type | Cell/stem cell | Fluorescent expressed | Culture medium | Supplements | Culture time (days) |
| Van De Looverbosch et al[33], 2025 | Suspension cells | 1000 and 2000 | Patient-derived | GSCs (LBT037-EGFP) | EGFP | Neurocult medium | bFGF, EGF, heparin, and anti-anti | NR |
| Ferreira et al[34], 2024 | Suspension cells | 100000 | Lineage | U343MG | GFP | DMEM | Anti-anti and FBS | NR |
| LN18 | ||||||||
| Pedrosa et al[25], 2023 | Spheres (grow up as tumor spheres in non-laminin coated plate) | NR | Patient-derived | Proneural (GIC7) | GFP | DMEM/F12 | EGF, bFGF, glucose, N2, glutamine, BSA, and HEPES | NR |
| Mesenchymal (PG88) | ||||||||
| Fedorova et al[35], 2023 | Spheres (poly-HEMA-treated ULA V-bottom 96-well plate + centrifuged (200 g/2 minute) | 2000 | Lineage | U87MG | GFP and tdTomato | DMEM/F12 | Glutamax, NEAA, PS, and FBS | 1 |
| Bassot et al[36], 2023 | Suspension cells | NR | Patient-derived | Classical GSC (Ge904) | Non-labeled | DMEM-high | Glucose, Glutamax, PS, and FBS | NR |
| Goranci-Buzhala et al[37], 2021 | Suspension cells | 1000 | Patient-derived | GSCs (U3047MG (OPC-like) | mCherry | Neurocult NS-A | EGF, bFGF, N2, L-glutamine, B27 without vitamin A, heparin, and BSA | NR |
| GSCs (U3024MG (MES-like) | ||||||||
| Azzarelli et al[14], 2021 | Suspension cells | 10000 or 50000 | Patient-derived | GSCs (GCGR-E27 and GCGR-E35) | H2B-GFP | D8437 | EGF, bFGF, N2, Glutamax, B27, PS, and laminin | NR |
| Krieger et al[38], 2020 | Suspension cells | 1000 | Patient-derived | 4 patient-derived cell lines | GFP | Neurobasal medium | EGF, bFGF, L-glutamine, B27, and heparin | 7-21 |
| Goranci-Buzhala et al[23], 2020 | Spheres (ULA U-bottom 96-well plate) | 1000 | Patient-derived | GSCs primary lines (U3047MG, U3024MG, 450) | mCherry | Neurocult NS-A | EGF, bFGF, N2, L-glutamin, B27 without vitamin A, heparin, and BSA | 2 |
| GSCs recurrent lines (275-BIS) | GFP | |||||||
| Linkous et al[24], 2019 | Suspension cells | 10000 | Patient-derived | GSCs | GFP | Neurobasal medium | bFGF, sodium, N2, B27, L-glutamine, and heparin | NR |
| RFP-827 |
- Citation: Alves ADH, Ennes do Valle NM, Yokota-Moreno BY, Galanciak MCDS, Felix da Silva K, Mamani JB, Sertie AL, de Oliveira FA, Nucci MP, Gamarra LF. Stem cell-derived neural organoids as platforms to investigate glioblastoma invasion and migration: A systematic review. World J Stem Cells 2025; 17(8): 108898
- URL: https://www.wjgnet.com/1948-0210/full/v17/i8/108898.htm
- DOI: https://dx.doi.org/10.4252/wjsc.v17.i8.108898